
Associate Professor Liauw graduated in Medicine from the University of Sydney in 1995, was awarded his Fellowships in Medical Oncology (2002) and Pharmacology (2003) by the Royal Australasian College of Physicians. He is a medical oncologist and clinical pharmacologist and currently practices both of these disciplines. He has completed a Masters degree in pharmaceutical development. He holds appointments at St George Public and Private Hospitals. His clinical practice is based around gastrointestinal cancer with a special focus on regional and intraperitoneal chemotherapy. His research interests are based around pharmaceutical development and he is currently a principal or co-investigator on numerous industry and investigator initiated clinical trials including phase 1 research. In this capacity he has provided consulting services for the biotechnology industry and contract research organisations. He has been actively involved in research ethics and regulation and is deputy chair of the Shared Scientific Assessment Scheme Core Committee and the Cancer Institute NSW Human Research Ethics Committee (Clinical Trials) and chair of the St George Hospital Human Research Ethics Committee. In 2010 he was appointed to the board of directors of the NPS Better Choices > Better Health. He has published the results of clinical trials, cancer outcomes research, on adverse event reporting in clinical trials and the review of clinical trial protocols. A/Prof Liauw‘s other interests include medical education and the use of information technology in medicine.